Literature DB >> 29936307

Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections.

Jennifer R Honda1, Scott Alper2, Xiyuan Bai3, Edward D Chan4.   

Abstract

Nontuberculous mycobacteria (NTM) are ubiquitous in the environment and human exposure is likely to be pervasive; yet, the occurrence of NTM-related diseases is relatively infrequent. This discrepancy suggests that host risk factors play an integral role in vulnerability to NTM infections. Isolated NTM lung disease (NTM-LD) is often due to underlying anatomical pulmonary or immune disorders, either of which may be acquired or genetic. However, many cases of NTM-LD have no known underlying risk factors and may be multigenic and/or multicausative. In contrast, extrapulmonary visceral or disseminated NTM diseases almost always have an underlying severe immunodeficiency, which may also be acquired or genetic. NTM cell wall components play a key role in pathogenesis and as inducers of the host immune response.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29936307     DOI: 10.1016/j.coi.2018.06.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  10 in total

1.  Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy.

Authors:  Kerstin Pohl; Xue A Grimm; Silvia M Caceres; Katie R Poch; Noel Rysavy; Milene Saavedra; Jerry A Nick; Kenneth C Malcolm
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

Review 2.  Nontuberculous mycobacteria in drinking water systems - the challenges of characterization and risk mitigation.

Authors:  Katherine Dowdell; Sarah-Jane Haig; Lindsay J Caverly; Yun Shen; John J LiPuma; Lutgarde Raskin
Journal:  Curr Opin Biotechnol       Date:  2019-04-16       Impact factor: 9.740

3.  Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection.

Authors:  Young Jae Kim; June-Young Lee; Jae Jin Lee; Sang Min Jeon; Prashanta Silwal; In Soo Kim; Hyeon Ji Kim; Cho Rong Park; Chaeuk Chung; Jeong Eun Han; Jee-Won Choi; Euon Jung Tak; Ji-Ho Yoo; Su-Won Jeong; Do-Yeon Kim; Warisa Ketphan; Su-Young Kim; Byung Woo Jhun; Jake Whang; Jin-Man Kim; Hyungjin Eoh; Jin-Woo Bae; Eun-Kyeong Jo
Journal:  Gut Microbes       Date:  2022 Jan-Dec

4.  Donor-defined mesenchymal stem cell antimicrobial potency against nontuberculous mycobacterium.

Authors:  Tracey L Bonfield; Morgan T Sutton; David R Fletcher; Michael A Folz; Vaishnavi Ragavapuram; Rodrigo A Somoza; Arnold I Caplan
Journal:  Stem Cells Transl Med       Date:  2021-05-04       Impact factor: 6.940

Review 5.  Host Immune Response and Novel Diagnostic Approach to NTM Infections.

Authors:  Yuko Abe; Kiyoharu Fukushima; Yuki Hosono; Yuki Matsumoto; Daisuke Motooka; Naoko Ose; Shota Nakamura; Seigo Kitada; Hiroshi Kida; Atsushi Kumanogoh
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

Review 6.  Host-Pathogen Interactions Operative during Mycobacteroides abscessus Infection.

Authors:  Eun-Jin Park; Prashanta Silwal; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2021-12-23       Impact factor: 6.303

Review 7.  The Rise of Non-Tuberculosis Mycobacterial Lung Disease.

Authors:  Champa N Ratnatunga; Viviana P Lutzky; Andreas Kupz; Denise L Doolan; David W Reid; Matthew Field; Scott C Bell; Rachel M Thomson; John J Miles
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561

8.  The Peroxisome Proliferator-Activated Receptor α- Agonist Gemfibrozil Promotes Defense Against Mycobacterium abscessus Infections.

Authors:  Yi Sak Kim; Jin Kyung Kim; Bui Thi Bich Hanh; Soo Yeon Kim; Hyeon Ji Kim; Young Jae Kim; Sang Min Jeon; Cho Rong Park; Goo Taeg Oh; June-Woo Park; Jin-Man Kim; Jichan Jang; Eun-Kyeong Jo
Journal:  Cells       Date:  2020-03-06       Impact factor: 6.600

9.  Characterization of integrated prophages within diverse species of clinical nontuberculous mycobacteria.

Authors:  Cody Glickman; Sara M Kammlade; Nabeeh A Hasan; L Elaine Epperson; Rebecca M Davidson; Michael Strong
Journal:  Virol J       Date:  2020-08-17       Impact factor: 4.099

Review 10.  Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.

Authors:  Deepshikha Verma; Edward D Chan; Diane J Ordway
Journal:  Vaccines (Basel)       Date:  2020-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.